Publications

December 11, 2023

ASH – 2023 – POSTER PRESENTATION – 4862

VCAR33 (Allogeneic)

Phase 1/2 Study of Donor-Derived Anti-CD33 Chimeric Antigen Receptor Expressing T Cells (VCAR33) in Patients with Relapsed or Refractory Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation